Identifying the links between obesity, insulin resistance and β-cell function:: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes

被引:228
作者
Greenberg, AS
McDaniel, ML [1 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[3] Tufts Univ New England Med Ctr, Tupper Res Inst, Div Endocrinol, Boston, MA 02111 USA
关键词
diabetes mellitus type 2; PPAR gamma; tumour necrosis factor-alpha; pathogenesis;
D O I
10.1046/j.1365-2362.32.s3.4.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A combination of insulin resistance and pancreatic beta-cell dysfunction underlies most cases of type 2 diabetes. While the interplay of these two impairments is believed to be important in the development and progression of type 2 diabetes, the mechanisms involved are unclear. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of type 2 diabetes mellitus. Pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-alpha) have deleterious effects on both glucose homeostasis and beta-cell function, and can disrupt insulin signalling pathways in both pancreatic beta cells and liver and adipose tissue. The anti-inflammatory activity of the thiazolidinedione anti-diabetic agents is potentially beneficial, given the possible role of pro-inflammatory cytokines in linking insulin resistance with beta-cell dysfunction.
引用
收藏
页码:24 / 34
页数:11
相关论文
共 121 条
  • [11] Nitric oxide and cellular respiration
    Brunori, M
    Giuffrè, A
    Sarti, P
    Stubauer, G
    Wilson, MT
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 56 (7-8) : 549 - 557
  • [12] Response of pancreatic β-cells to improved insulin sensitivity in women at high risk for type 2 diabetes
    Buchanan, TA
    Xiang, AH
    Peters, RK
    Kjos, SL
    Berkowitz, K
    Marroquin, A
    Goico, J
    Ochoa, C
    Azen, SP
    [J]. DIABETES, 2000, 49 (05) : 782 - 788
  • [13] Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats
    Buckingham, RE
    Al-Barazanji, KA
    Toseland, CDN
    Slaughter, M
    Connor, SC
    West, A
    Bond, B
    Turner, NC
    Clapham, JC
    [J]. DIABETES, 1998, 47 (08) : 1326 - 1334
  • [14] INTERFERON-GAMMA - PLEIOTROPIC EFFECTS ON A RAT PANCREATIC BETA-CELL LINE
    CAMPBELL, IL
    OXBROW, L
    HARRISON, LC
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1987, 52 (1-2) : 161 - 167
  • [15] IMPACT OF OBESITY ON INSULIN ACTION IN VOLUNTEERS WITH NORMAL GLUCOSE-TOLERANCE - DEMONSTRATION OF A THRESHOLD FOR THE ADVERSE EFFECT OF OBESITY
    CAMPBELL, PJ
    GERICH, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) : 1114 - 1118
  • [16] Carey DG, 2000, DIABETOLOGIA, V43, pA68
  • [17] CLINICAL REVIEW .26. INSULIN RESISTANCE IN OBESE AND NONOBESE MAN
    CARO, JF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (04) : 691 - 695
  • [18] ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS
    CARSWELL, EA
    OLD, LJ
    KASSEL, RL
    GREEN, S
    FIORE, N
    WILLIAMSON, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) : 3666 - 3670
  • [19] Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
    Cavaghan, MK
    Ehrmann, DA
    Byrne, MM
    Polonsky, KS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) : 530 - 537
  • [20] Interactions between insulin resistance and insulin secretion in the development of glucose intolerance
    Cavaghan, MK
    Ehrmann, DA
    Polonsky, KS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (03) : 329 - 333